Entera Bio

Entera Bio Inventory

The Inventory of Entera Bio (ENTX) as of Oct 8, 2026 is -294,000.00 USD. In the previous year, Inventory was -93,000.00 USD — a change of 216.13% (lower).

Inventory

-294,000.00USD

YoY

216.13%

Last updated:

Inventory of Entera Bio is 2022 -294,000.00 USD. Inventory of Entera Bio was 2021 -93,000.00 USD. It decreases by 216.13% lower compared to the previous year.

The Entera Bio Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
130,000.00 USD
Jan 1, 2019
76,000.00 USD
Jan 1, 2020
-93,000.00 USD
Jan 1, 2022
-294,000.00 USD
The Entera Bio Inventory history
YEARInventoryYoY
-294,000.00USD+216.13%
-93,000.00USD-222.37%
76,000.00USD-41.54%
130,000.00USD—
Access this data via the Eulerpool API
Get Free API Key

Entera Bio Stock analysis

What does Entera Bio do? Entera Bio Ltd is an emerging biotechnology company focused on developing oral medications to treat unmet medical needs. The company was founded in 2010 and is headquartered in Jerusalem, Israel. Its history began with the discovery of the "EnteraGam" molecule in the intestinal cells of breastfed infants, which helps them fight infections. This led to the development of EnteraGam for the treatment of various autoimmune diseases. The company's business model is based on developing oral formulations for existing drugs and discovering and developing new molecules. Its focus areas are osteoporosis, hypoparathyroidism, chronic kidney disease, and autoimmune diseases. Entera Bio is divided into three business divisions: the Oral Protein Delivery Platform, the Oral Parathyroid Hormone (PTH) Platform, and the Collagen-based Platform for Wound Healing. Its products include EB611, a candidate for hypoparathyroidism treatment, EB613 for osteoporosis treatment, and EB612 for chronic kidney disease. These products have potential to improve the lives of millions of patients worldwide. Entera Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Entera Bio stock

Inventory of Entera Bio is -294,000.00 USD in 2022.

Inventory of Entera Bio changed from -93,000.00 USD to -294,000.00 USD, representing a 216.13% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory Entera Bio since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Entera Bio historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Entera Bio

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Entera Bio